3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
The potential of a spheroid tumor model composed of cells in different proliferative and metabolic states for the development of new anticancer strategies has been amply demonstrated. However, there is little or no information in the literature on the problems of reproducibility of data originating from experiments using 3D models. Our analyses, carried out using a novel open source software capable of performing an automatic image analysis of 3D tumor colonies, showed that a number of morphology parameters affect the response of large spheroids to treatment. In particular, we found that both spheroid volume and shape may be a source of variability. We also compared some commercially available viability assays specifically designed for 3D models. In conclusion, our data indicate the need for a pre-selection of tumor spheroids of homogeneous volume and shape to reduce data variability to a minimum before use in a cytotoxicity test. In addition, we identified and validated a cytotoxicity test capable of providing meaningful data on the damage induced in large tumor spheroids of up to diameter in 650 μm by different kinds of treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent progress has directed the development of high-throughput methods for uniform spheroid assembly and continuous perfusable culture that secure reproducibility [92].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [92]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Commercial kits, such as CellTiter-Glo® 3D and Cultrex® 3D viability assays, are designed to enhance lysis efficiency and signal uniformity in spheroids [15,307].”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [307]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
In VitroChondrogenesis of Bone Marrow-Derived Mesenchymal Progenitor Cells
Johnstone, B., Hering, T. M., Caplan, A. I., Goldberg, V. M., & Yoo, J. U. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3858 · Cited by 2,382
Optical Sectioning Deep Inside Live Embryos by Selective Plane Illumination Microscopy
Huisken, J., Swoger, J., Del Bene, F., Wittbrodt, J., & Stelzer, E. H. K. (2004) · Science · doi:10.1126/science.1100035 · Cited by 2,355
Deconstructing the third dimension – how 3D culture microenvironments alter cellular cues
Baker, B. M., & Chen, C. S. (2012) · Journal of Cell Science · doi:10.1242/jcs.079509 · Cited by 1,760
Modeling Tissue Morphogenesis and Cancer in 3D
Yamada, K. M., & Cukierman, E. (2007) · Cell · doi:10.1016/j.cell.2007.08.006 · Cited by 1,751
Spheroid-based drug screen: Considerations and practical approach
Friedrich, J., Seidel, C., Ebner, R., & Kunz-Schughart, L. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.226 · Cited by 1,742
Multicellular tumor spheroids: An underestimated tool is catching up again
Hirschhaeuser, F., Menne, H., Dittfeld, C., West, J., Mueller-Klieser, W., & Kunz-Schughart, L. A. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.01.012 · Cited by 1,674
Three-dimensional culture models of normal and malignant breast epithelial cells
Lee, G. Y., Kenny, P. A., Lee, E. H., & Bissell, M. J. (2007) · Nature Methods · doi:10.1038/nmeth1015 · Cited by 1,336 · cited 1×
“(5) The final volume is automatically estimated by counting the voxels bound by the surface and using the x-y pixel resolution coefficient to convert voxels to μ M3.”
MethodOpportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy
Mehta, G., Hsiao, A. Y., Ingram, M., Luker, G. D., & Takayama, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.045 · Cited by 1,172
Spherical Cancer Models in Tumor Biology
Weiswald, L.-B., Bellet, D., & Dangles-Marie, V. (2015) · Neoplasia · doi:10.1016/j.neo.2014.12.004 · Cited by 1,141
Cited by
Nunes, A. S., Barros, A. S., Costa, E. C., Moreira, A. F., & Correia, I. J. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26845 · Cited by 721
“optimized to reduce the cost and the lab work, as well as to allow the production of a large number of spheroids, under controlled conditions and compatible with all the cancer cell lines (Zanoni et al., 2016).”
BackgroundMethodSystems Biology of Cancer Metastasis
Suhail, Y., Cain, M. P., Vanaja, K., Kurywchak, P. A., Levchenko, A., Kalluri, R., & Kshitiz (2019) · Cell Systems · doi:10.1016/j.cels.2019.07.003 · Cited by 452
“…that can be perturbed with relative ease, while also being able to incorporate some of the complexity of tumor microenvironments such as variations in mechanical properties, matrix chemistry, paracrine signals, and cell-cell interactions(Katt et al., 2016; Singh et al., 2018; Zanoni et al., 2016).”
BackgroundThree-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research
Pinto, B., Henriques, A. C., Silva, P. M. A., & Bousbaa, H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121186 · Cited by 440
Challenges of applying multicellular tumor spheroids in preclinical phase
Han, S. J., Kwon, S., & Kim, K. S. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01853-8 · Cited by 428
3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions
Rodrigues, J., Heinrich, M. A., Teixeira, L. M., & Prakash, J. (2021) · Trends in Cancer · doi:10.1016/j.trecan.2020.10.009 · Cited by 405
Comparison of 2D and 3D cell culture models for cell growth, gene expression and drug resistance
Fontoura, J. C., Viezzer, C., dos Santos, F. G., Ligabue, R. A., Weinlich, R., Puga, R. D., Antonow, D., Severino, P., & Bonorino, C. (2020) · Materials Science and Engineering: C · doi:10.1016/j.msec.2019.110264 · Cited by 388
“accessibility and increased acidity and waste products [38].”
BackgroundImmuno-Oncology: Emerging Targets and Combination Therapies
Marshall, H. T., & Djamgoz, M. B. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00315 · Cited by 301
Upadhyay, S., & Palmberg, L. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy053 · Cited by 292
Barbosa, M. A. G., Xavier, C. P. R., Pereira, R. F., Petrikaitė, V., & Vasconcelos, M. H. (2021) · Cancers · doi:10.3390/cancers14010190 · Cited by 285
“One of the main problems behind the transition from 2D to 3D cell culture for drug screening is the fact that tools and equipment available to evaluate cytotoxicity, investigate gene and protein expressions, among other assay endpoints, are difficult to apply to 3D models [10,32].”
BackgroundMethodInfluentialPhan, N., Hong, J. J., Tofig, B., Mapua, M., Elashoff, D., Moatamed, N. A., Huang, J., Memarzadeh, S., Damoiseaux, R., & Soragni, A. (2019) · Communications Biology · doi:10.1038/s42003-019-0305-x · Cited by 269
Moshksayan, K., Kashaninejad, N., Warkiani, M. E., Lock, J. G., Moghadas, H., Firoozabadi, B., Saidi, M. S., & Nguyen, N.-T. (2018) · Sensors and Actuators B: Chemical · doi:10.1016/j.snb.2018.01.223 · Cited by 267
Three-dimensional in vitro culture models in oncology research
Jubelin, C., Muñoz-Garcia, J., Griscom, L., Cochonneau, D., Ollivier, E., Heymann, M.-F., Vallette, F. M., Oliver, L., & Heymann, D. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00887-3 · Cited by 264
Lin, A., Hu, Q., Li, C., Xing, Z., Ma, G., Wang, C., Li, J., Ye, Y., Yao, J., Liang, K., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3473 · Cited by 263
Melissaridou, S., Wiechec, E., Magan, M., Jain, M. V., Chung, M. K., Farnebo, L., & Roberg, K. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0733-1 · Cited by 262
Modeling neoplastic disease with spheroids and organoids
Zanoni, M., Cortesi, M., Zamagni, A., Arienti, C., Pignatta, S., & Tesei, A. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00931-0 · Cited by 261
Self-citationCyclometalated iridium(III) complexes for life science
Caporale, C., & Massi, M. (2018) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.02.006 · Cited by 258
Roovers, S., Segers, T., Lajoinie, G., Deprez, J., Versluis, M., De Smedt, S. C., & Lentacker, I. (2019) · Langmuir · doi:10.1021/acs.langmuir.8b03779 · Cited by 256
Design of spherically structured 3D in vitro tumor models -Advances and prospects
Ferreira, L. P., Gaspar, V. M., & Mano, J. F. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.05.034 · Cited by 249
“microtissues size and morphology with variability in phenotype, gene expression profile, as well as with the degree of response to anti-cancer or anti-stromal therapeutics [20,21].”
BackgroundMethodMulticellular Tumor Spheroids (MCTS) as a 3D In Vitro Evaluation Tool of Nanoparticles
Lu, H., & Stenzel, M. H. (2018) · Small · doi:10.1002/smll.201702858 · Cited by 231
Costa, E. C., de Melo‐Diogo, D., Moreira, A. F., Carvalho, M. P., & Correia, I. J. (2018) · Biotechnology Journal · doi:10.1002/biot.201700417 · Cited by 224
Amaral, R. L. F., Miranda, M., Marcato, P. D., & Swiech, K. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00605 · Cited by 222
“According to the sphericity index values, tumor aggregates could be also classified as spherical (SI ≥ 0.90) or non-spherical shape (SI 0.90), the latter being subdivided into ellipsoidal, “8”- shaped, and irregular (Zanoni et al., 2016).”
BackgroundInfluentialOrgan-on-chip models of cancer metastasis for future personalized medicine: From chip to the patient
Caballero, D., Kaushik, S., Correlo, V. M., Oliveira, J. M., Reis, R. L., & Kundu, S. C. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.005 · Cited by 221
Applications of Surface Modification Technologies in Nanomedicine for Deep Tumor Penetration
Li, Z., Shan, X., Chen, Z., Gao, N., Zeng, W., Zeng, X., & Mei, L. (2021) · Advanced Science · doi:10.1002/advs.202002589 · Cited by 218
Regulation of Tumor Progression by Programmed Necrosis
Lee, S. Y., Ju, M. K., Jeon, H. M., Jeong, E. K., Lee, Y. J., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3537471 · Cited by 215
“Thus, it is now commonly accepted that MTS can be used for drug screening [72, 73].”
BackgroundThree‐dimensional cell culture models for anticancer drug screening: Worth the effort?
Verjans, E., Doijen, J., Luyten, W., Landuyt, B., & Schoofs, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26052 · Cited by 212
“A similar observation was made by Zanoni et al. (2015) who showed that 3D cell cultures heterogeneous in shape and volume may respond differently to chemical or physical treatments.”
BackgroundLazzari, G., Couvreur, P., & Mura, S. (2017) · Polymer Chemistry · doi:10.1039/c7py00559h · Cited by 200
High-Content Monitoring of Drug Effects in a 3D Spheroid Model
Mittler, F., Obeïd, P., Rulina, A. V., Haguet, V., Gidrol, X., & Balakirev, M. Y. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00293 · Cited by 194
Zoetemelk, M., Rausch, M., Colin, D., Dormond, O., & Nowak-Sliwinska, P. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-42836-0 · Cited by 175
Huang, B.-W., & Gao, J.-Q. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.005 · Cited by 174
Engineering 3D Hydrogels for Personalized In Vitro Human Tissue Models
Liaw, C., Ji, S., & Guvendiren, M. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701165 · Cited by 170
Hou, S., Tiriac, H., Sridharan, B. P., Scampavia, L., Madoux, F., Seldin, J., Souza, G. R., Watson, D., Tuveson, D., & Spicer, T. P. (2018) · SLAS Discovery · doi:10.1177/2472555218766842 · Cited by 169
“Traditional monolayer cancer models exhibit an unrestrained proliferation phenotype, which has proven limited value in predicting clinical response to novel agents.(1) 3D ex vivo tumor models are able to better recapitulate the features of in vivo cancer, such as cell–cell interactions, cell– matrix interactions, hypo…”
BackgroundPiccinini, F., Tesei, A., Arienti, C., & Bevilacqua, A. (2017) · Biological Procedures Online · doi:10.1186/s12575-017-0056-3 · Cited by 164
Self-citationMetabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment
Sharick, J. T., Walsh, C. M., Sprackling, C. M., Pasch, C. A., Pham, D. L., Esbona, K., Choudhary, A., García‐Varela, R., Burkard, M. E., McGregor, S. M., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00553 · Cited by 162
“and heterogeneity between hollow and solid organoids were also expected, as heterogeneity-driving gradients of oxygen and nutrients are known to form within solid tumor spheroids (70).”
BackgroundA three-dimensional spheroidal cancer model based on PEG-fibrinogen hydrogel microspheres
Pradhan, S., Clary, J. M., Seliktar, D., & Lipke, E. A. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.052 · Cited by 161
Hybrid collagen alginate hydrogel as a platform for 3D tumor spheroid invasion
Liu, C., Mejia, D. L., Chiang, B., Luker, K. E., & Luker, G. D. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.06.003 · Cited by 161
Baldassi, D., Gabold, B., & Merkel, O. M. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202000111 · Cited by 160
Mondal, A., Gebeyehu, A., Miranda, M., Bahadur, D., Patel, N., Ramakrishnan, S., Rishi, A. K., & Singh, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-55034-9 · Cited by 160
Low, L. E., Tan, L. T.-H., Goh, B.-H., Tey, B. T., Ong, B. H., & Tang, S. Y. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.01.037 · Cited by 159
Zhou, X., Luo, Z., Baidya, A., Kim, H., Wang, C., Jiang, X., Qu, M., Zhu, J., Ren, L. M., Vajhadin, F., et al. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000527 · Cited by 156
A versatile 3D tissue matrix scaffold system for tumor modeling and drug screening
Rijal, G., & Li, W. (2017) · Science Advances · doi:10.1126/sciadv.1700764 · Cited by 154
Digesting a Path Forward: The Utility of Collagenase Tumor Treatment for Improved Drug Delivery
Dolor, A., & Szoka, F. C. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00319 · Cited by 153
Decarli, M. C., do Amaral, R. L. F., dos Santos, D. P., Tofani, L. B., Katayama, E. T., Rezende, R. A., da Silva, J. V. L., Swiech, K., Suazo, C. A. T., Mota, C., et al. (2021) · Biofabrication · doi:10.1088/1758-5090/abe6f2 · Cited by 153
“…shown both through experimental data and mathematical modeling that there are other more complex parameters and relationships involved in the development of necrosis, such as nutrient consumption and depletion, as well as metabolite accumulation described by the theory of diffusion [24, 73, 74].”
InfluentialMimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling
Shukla, P., Yeleswarapu, S., Heinrich, M. A., Prakash, J., & Pati, F. (2022) · Biofabrication · doi:10.1088/1758-5090/ac6d11 · Cited by 148
“The major drawback of preexisting cancer models lies in replicating exact human physiological conditions and associated functionality within these 3D tumor models [80–82].”
Bioprinting a novel glioblastoma tumor model using a fibrin-based bioink for drug screening
Lee, C., Abelseth, E., la Vega, L. D., & Willerth, S. M. (2019) · Materials Today Chemistry · doi:10.1016/j.mtchem.2018.12.005 · Cited by 146
Cells grown in three-dimensional spheroids mirror in vivo metabolic response of epithelial cells
Lagies, S., Schlimpert, M., Neumann, S., Waeldin, A., Kammerer, B., Borner, C., & Peintner, L. (2020) · Communications Biology · doi:10.1038/s42003-020-0973-6 · Cited by 145
In Vitro Tissue‐Engineered Skeletal Muscle Models for Studying Muscle Physiology and Disease
Khodabukus, A., Prabhu, N. K., Wang, J., & Bursac, N. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701498 · Cited by 143
Mulholland, T., McAllister, M. J., Patek, S., Flint, D., Underwood, M., Sim, A., Edwards, J., & Zagnoni, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-33055-0 · Cited by 139
Tumor cells and their crosstalk with endothelial cells in 3D spheroids
Shoval, H., Karsch-Bluman, A., Brill-Karniely, Y., Stern, T., Zamir, G., Hubert, A., & Benny, O. (2017) · Scientific Reports · doi:10.1038/s41598-017-10699-y · Cited by 138
Challenges for optical nanothermometry in biological environments
Quintanilla, M., Henriksen‐Lacey, M., Renero‐Lecuna, C., & Liz‐Marzán, L. M. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00069e · Cited by 130
A novel 3D breast-cancer-on-chip platform for therapeutic evaluation of drug delivery systems
Chen, Y., Gao, D., Wang, Y., Lin, S., & Jiang, Y. (2018) · Analytica Chimica Acta · doi:10.1016/j.aca.2018.06.038 · Cited by 128
Allgayer, H., Mahapatra, S., Mishra, B., Swain, B., Saha, S., Khanra, S., Kumari, K., Panda, V. K., Malhotra, D., Patil, N. S., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02338-2 · Cited by 127
“Spheroid tumor models, which are composed of cells in various metabolic and proliferative states, have been shown to have great potential for the development of novel anticancer therapies [168].”
Karolak, A. M., Markov, D. A., McCawley, L. J., & Rejniak, K. A. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0703 · Cited by 127
Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer
Emmings, E., Mullany, S. A., Chang, Z., Landen, C. N., Linder, S. T., & Bazzaro, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010229 · Cited by 127
Impedance Spectroscopy as a Tool for Monitoring Performance in 3D Models of Epithelial Tissues
Gerasimenko, T. N., Nikulin, S. V., Захарова, Г. С., Poloznikov, A. A., Petrov, V., Baranova, A. V., & Tonevitsky, A. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00474 · Cited by 127
“The most widely used 3D cell culture technique produces so-called spheroids (Zanoni et al., 2016), which are formed by suspended cells either spontaneously or under the influence of various external factors.”
MethodTowards extracellular matrix normalization for improved treatment of solid tumors
Abyaneh, H. S., Regenold, M., McKee, T. D., Allen, C. J., & Gauthier, M. A. (2020) · Theranostics · doi:10.7150/thno.39995 · Cited by 127
“spheroids may provide more reliable results since they recapitulate some features of the non-vascularized tumor such as an inhibitory ECM, epithelial tight junctions, and an outer proliferating region that surrounds intermediate layers of quiescent cells along with a necrotic core [195].”
BackgroundAnagnostidis, V., Sherlock, B. E., Metz, J., Mair, P., Hollfelder, F., & Gielen, F. (2020) · Lab on a Chip · doi:10.1039/d0lc00055h · Cited by 123
ECM deposition is driven by caveolin-1–dependent regulation of exosomal biogenesis and cargo sorting
Albacete-Albacete, L., Navarro‐Lérida, I., López, J. A., Martín-Padura, I., Astudillo, A. M., Ferrarini, A., van der Heyden, M., Balsinde, J., Orend, G., Vázquez, J., et al. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.202006178 · Cited by 122
“We studied the ability of exosomes to deposit ECM on MDAMB468 spheroids, scaffold-free 3D assemblies in which cells self-organize ECM and engage in intercellular communication and which have been validated as superior in vitro experimental proxies of live tissues for many applications (Fennema et al., 2013; Zanoni et…”
BackgroundA 3D printed microfluidic perfusion device for multicellular spheroid cultures
Ong, L. J. Y., Islam, A., DasGupta, R., Iyer, N. G., Leo, H. L., & Toh, Y. (2017) · Biofabrication · doi:10.1088/1758-5090/aa8858 · Cited by 121
Dabbagh, S. R., Sarabi, M. R., Birtek, M. T., Mustafaoğlu, N., Zhang, Y. S., & Taşoğlu, S. (2022) · Aggregate · doi:10.1002/agt2.197 · Cited by 119
Drug screening in 3D in vitro tumor models: overcoming current pitfalls of efficacy read‐outs
Santo, V. E., Rebelo, S. P., Estrada, M. F., Alves, P. M., Boghaert, E. R., & Brito, C. (2016) · Biotechnology Journal · doi:10.1002/biot.201600505 · Cited by 118
“These assays need to be thoroughly validated for a proper application in 3D tumor cell cultures, aiming to attain reproducibility [5, 53].”
BackgroundAnticancer drug discovery using multicellular tumor spheroid models
Zanoni, M., Pignatta, S., Arienti, C., Bonafè, M., & Tesei, A. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1570129 · Cited by 117
Self-citationBadr-Eldin, S. M., Aldawsari, H. M., Kotta, S., Deb, P. K., & Venugopala, K. N. (2022) · Pharmaceuticals · doi:10.3390/ph15080926 · Cited by 117
“The technique was successfully applied for in vitro breast cancer tumor formation, mimicking the properties of human in vivo tumors [70].”
MethodPatrizii, M., Bartucci, M., Pine, S. R., & Sabaawy, H. E. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00023 · Cited by 113
Gencoglu, M. F., Barney, L. E., Hall, C. L., Brooks, E. A., Schwartz, A. D., Corbett, D. C., Stevens, K. R., & Peyton, S. R. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00069 · Cited by 110
Huang, Y., Wang, S., Guo, Q., Kessel, S. L., Rubinoff, I., Chan, L. L., Li, P., Liu, Y., Qiu, J., & Zhou, C. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0821 · Cited by 110
“alternative to create a high-resolution, 3D profile of an entire tumor spheroid (11,25).”
3D cancer models: One step closer to in vitro human studies
Manduca, N., Maccafeo, E., Maria, R. D., Sistigu, A., & Musella, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1175503 · Cited by 108
Influence of Matrigel on Single- and Multiple-Spheroid Cultures in Breast Cancer Research
Badea, M. A., Balaș, M., Hermenean, A. O., Ciceu, A., Herman, H., Ioniță, D., & Dinischiotu, A. (2019) · SLAS DISCOVERY · doi:10.1177/2472555219834698 · Cited by 105
Szöőr, Á., Tóth, G., Zsebik, B., Szabó, V., Eshhar, Z., Abken, H., & Vereb, G. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.04.008 · Cited by 105
“NK-92 and HER2-CAR T cells are likewise efficacious in three-dimensional cultures with an established extracellular matrix [25].”
BackgroundMISpheroID: a knowledgebase and transparency tool for minimum information in spheroid identity
Peirsman, A., Blondeel, E., Ahmed, T., Anckaert, J., Audenaert, D., Boterberg, T., Buzás, K., Carragher, N. O., Castellani, G., Castro, F., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01291-4 · Cited by 105
Self-citationBaker, A. E. G., Tam, R. Y., & Shoichet, M. S. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b01422 · Cited by 104
Tosca, E. M., Ronchi, D., Facciolo, D., & Magni, P. (2023) · Biomedicines · doi:10.3390/biomedicines11041058 · Cited by 103
Lim, W., & Park, S. (2018) · Molecules · doi:10.3390/molecules23123355 · Cited by 102
Recent Advances in Multicellular Tumor Spheroid Generation for Drug Screening
Lee, K.-H., & Kim, T. P. (2021) · Biosensors · doi:10.3390/bios11110445 · Cited by 102
“Multicellular spheroids are used in drug screening tools as an in-vitro spheroid model for the selection and identification of drug candidates [112].”
MethodSuzuki, K., Miura, Y., Mochida, Y., Miyazaki, T., Toh, K., Anraku, Y., Melo, V. A., Liu, X., Ishii, T., Nagano, O., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.02.021 · Cited by 101
Obaid, G., Bano, S., Mallidi, S., Broekgaarden, M., Kuriakose, J., Silber, Z., Bulin, A., Wang, Y.-C., Mai, Z., Jin, W., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b00859 · Cited by 101
Avci, N. G., Pustchi, S. E., Akay, Y. M., Esquenazi, Y., Tandon, N., Zhu, J., & Akay, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-70392-5 · Cited by 101
Critical Role of Three-Dimensional Tumorsphere Size on Experimental Outcome
Singh, S. K., Abbas, S., Saxena, A. K., Tiwari, S., Sharma, L. K., & Tiwari, M. (2020) · BioTechniques · doi:10.2144/btn-2020-0081 · Cited by 101
Current Advances in 3D Bioprinting for Cancer Modeling and Personalized Medicine
Germain, N., Dhayer, M., Dekiouk, S., & Marchetti, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073432 · Cited by 101
“Kits have been developed and adapted for 3D hydrogels, such as Celltiter-Glo 3D, which favors the penetration of reagents and has a better lytic capacity [101,116,122].”
MethodJamali, T., Kavoosi, G., Safavi, M., & Ardestani, S. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-34055-w · Cited by 100
Thomsen, A. R., Aldrian, C. J., Bronsert, P., Thomann, Y., Nanko, N., Mélin, N., Rücker, G., Follo, M., Grosu, A., Niedermann, G., et al. (2017) · Lab on a Chip · doi:10.1039/c7lc00832e · Cited by 99
Automation, Monitoring, and Standardization of Cell Product Manufacturing
Doulgkeroglou, M.-N., Di Nubila, A., Niessing, B., König, N., Schmitt, R. H., Damen, J., Szilvassy, S. J., Chang, W., Csontos, L., Louis, S., et al. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00811 · Cited by 98
“, 2012) and constitute the first choice in cancer models and evaluation of anti-cancer drugs (Chatzinikolaidou, 2016; Zanoni et al., 2016; Rodrigues et al., 2018).”
BackgroundUtama, R. H., Atapattu, L., O’Mahony, A. P., Fife, C. M., Baek, J., Allard, T., O'Mahony, K. J., Ribeiro, J. C. C., Gaus, K., Kavallaris, M., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101621 · Cited by 98
Biomimetic tumor microenvironments based on collagen matrices
Sapudom, J., & Pompe, W. (2018) · Biomaterials Science · doi:10.1039/c8bm00303c · Cited by 97
Lazzari, G., Vinciguerra, D., Balasso, A., Nicolas, V., Goudin, N., Garfa‐Traoré, M., Fehér, A., Dinnyés, A., Nicolas, J., Couvreur, P., et al. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.06.019 · Cited by 97
Eilenberger, C., Rothbauer, M., Selinger, F., Gerhartl, A., Jordan, C., Harasek, M., Schädl, B., Grillari, J., Weghuber, J., Neuhaus, W., et al. (2021) · Advanced Science · doi:10.1002/advs.202004856 · Cited by 97
Sarcoma Spheroids and Organoids—Promising Tools in the Era of Personalized Medicine
Colella, G., Fazioli, F., Gallo, M., Chiara, A. D., Apice, G., Ruosi, C., Cimmino, A., & de Nigris, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020615 · Cited by 96
Zhang, L., Wang, P., Zhou, X., Bretin, L., Zeng, X., Husiev, Y., Polanco, E. A., Zhao, G., Wijaya, L. S., Biver, T., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c04855 · Cited by 95
Pereira, P. M. R., Berisha, N., Bhupathiraju, N. V. S. D. K., Fernandes, R., Tomé, J. P. C., & Drain, C. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177737 · Cited by 93
Puls, T. J., Tan, X., Husain, M., Whittington, C. F., Fishel, M. L., & Voytik‐Harbin, S. L. (2018) · Scientific Reports · doi:10.1038/s41598-018-31138-6 · Cited by 92
Zhou, X., Xiao, M., Ramu, V., Hilgendorf, J., Li, X., Papadopoulou, P., Siegler, M. A., Kros, A., Sun, W. C., & Bonnet, S. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c01369 · Cited by 92
3D Culture Systems for Exploring Cancer Immunology
Fitzgerald, A. A., Li, E., & Weiner, L. M. (2020) · Cancers · doi:10.3390/cancers13010056 · Cited by 91
A reproducible scaffold-free 3D organoid model to study neoplastic progression in breast cancer
Djomehri, S. I., Burman, B., González, M. E., Takayama, S., & Kleer, C. G. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-018-0498-7 · Cited by 90
“Some investigators advised monitoring a combination of morphological parameters (Kelm et al. 2003; Celli et al. 2014; Zanoni et al. 2016) such as volume, sphericity, and area, however this information can be quite variable in the literature, stemming from inconsistencies in reproducibility and…”
BackgroundQayyum, A. S., Jain, E., Kolar, G., Kim, Y., Sell, S. A., & Zustiak, S. P. (2017) · Biofabrication · doi:10.1088/1758-5090/aa703c · Cited by 89
Engineered tissues and strategies to overcome challenges in drug development
Khalil, A. S., Jaenisch, R., & Mooney, D. J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.09.012 · Cited by 89
“For example, in a cell aggregate 3D tumor model, significant variance results from forming cell aggregates via different methods, leading to challenges in making simple measurements such as cell viability in 3D [166].”
Relevance of 3d culture systems to study osteosarcoma environment
Luca, A. D., Raimondi, L., Salamanna, F., Carina, V., Costa, V., Bellavia, D., Alessandro, R., Fini, M., & Giavaresi, G. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0663-5 · Cited by 88
A 3D Biohybrid Real‐Scale Model of the Brain Cancer Microenvironment for Advanced In Vitro Testing
Tricinci, O., Pasquale, D. D., Marino, A., Battaglini, M., Pucci, C., & Ciofani, G. (2020) · Advanced Materials Technologies · doi:10.1002/admt.202000540 · Cited by 87
Drosophila melanogaster: A platform for anticancer drug discovery and personalized therapies
Munnik, C., Xaba, M. P., Malindisa, S. T., Russell, B. L., & Sooklal, S. A. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.949241 · Cited by 87
“This has been found to influence drug efficacy and toxicity (Zanoni et al., 2016).”
BackgroundRijal, G., & Li, W. (2018) · Journal of Biological Engineering · doi:10.1186/s13036-018-0114-7 · Cited by 86
Weng, K., Kurokawa, Y. K., Hajek, B., Paladin, J. A., Shirure, V. S., & George, S. C. (2019) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2019.0248 · Cited by 85
3D culture technologies of cancer stem cells: promising ex vivo tumor models
Zhang, C., Yang, Z., Dong, D.-L., Jang, T., Knowles, J. C., Kim, H., Jin, G., & Xuan, Y. (2020) · Journal of Tissue Engineering · doi:10.1177/2041731420933407 · Cited by 85
Metadata
- Authors
- Zanoni, M., Piccinini, F., Arienti, C., Zamagni, A., Santi, S., Polico, R., Bevilacqua, A., & Tesei, A.
- Affiliations
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT)
- University of Bologna (IT)
- Istituto Ortopedico Rizzoli (IT)
- Corresponding author
- Tesei, Anna
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-01-11
- Volume
- 6
- Issue
- 1
- Pages
- 19103-19103
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4707510
- OpenAlex
- W2236643502
- Cited by
- 1,144
- References
- 43
- Citations by year
- 2026: 97 · 2025: 127 · 2024: 124 · 2023: 105 · 2022: 112 · 2021: 117 · 2020: 138 · 2019: 118 · 2018: 118 · 2017: 70 · 2016: 17
- FWCI
- 57.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
- Funders
- Ministero della Salute
- Istituto Ortopedico Rizzoli di Bologna
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Keywords
- tumor spheroids, spheroid morphology, automated image analysis, viability assay, cytotoxicity assay
- MeSH terms
- Cell Survival, Drug Screening Assays, Antitumor, Fibroblasts, Humans, Models, Biological, Tumor Cells, Cultured, Reproducibility of Results, Spheroids, Cellular, Imaging, Three-Dimensional, Cell Shape
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.